Summary of Significant Accounting Policies (Tables)

9 Months Ended

Dec. 31, 2014

Summary of Significant Accounting Policies (Tables)

Subsidiaries of the Company

The Company's consolidated subsidiaries and/or entities are as follows:

Name of consolidated subsidiary or entity	State or other jurisdiction of incorporation or organization	Date of incorporation or formation (date of acquisition, if applicable)	Attributable interest
Stevia Ventures International Ltd.	The Territory of the British Virgin Islands	April 11, 2011		100	%
Stevia Asia Limited	Hong Kong SAR	March 19, 2012		100	%
Stevia Technew Limited	Hong Kong SAR	April 28, 2012		70	%
SC Brands Pte Ltd	Singapore	October 1, 2013		100	%
Real Hemp, LLC	State of Indiana	February 24, 2014		100	%
SC Royal Andaman Services Co., Ltd.	Myanmar	August 15, 2014		70	%

Intangible Assets Other Than Goodwill Estimated Useful Live

Under the requirements, the Company amortizes the acquisition costs of intangible assets other than goodwill on a straight-line basis over the estimated useful lives of the respective assets as follows:

	Estimated Useful Life (Years)
Acquired technology		15
Website development costs		5

Schedule of contingent shares issuance arrangement, stock options or warrants

The Company’s contingent shares issuance arrangement, stock options or warrants are as follows:

	Contingent shares issuance arrangement, stock options or warrants
	For the Reporting Period Ended December 31, 2014		For the Reporting Period Ended December 31, 2013
Convertible Note Shares
On February 26, 2013, the Company issued two (2) convertible notes in the principal amount of $250,000 and $100,000, respectively, convertible at $0.25 per share, with interest at 12% per annum due on September 30, 2013. The Convertible Note in the principal amount of $250,000 with the accrued interest of $29,945 was converted to 1,124,274 shares on March 11, 2014. The Convertible Note in the principal amount of $100,000 is currently past due with no penalty and the Company continues to accrue the interest at 12% per annum.		400,000		1,400,000
On March 7, 2012, the Company issued a convertible note in the principal amount of $200,000 with interest at 10% per annum due one (1) year from the date of issuance with the conversion price to be the same as the next private placement price on a per share basis, provided that the Company completes a private placement with gross proceeds of at least $100,000. On August 6, 2012, the Company completed the very next private placement at $0.46875 per share with gross proceeds of at least $100,000. On March 15, 2013, the above note was cancelled and reissued with a new convertible note consisting of the prior principal amount and the entire accrued unpaid interest for the total amount of $220,438 with interest at 12% per annum convertible at $0.25 per share due on September 30, 2013. The note is currently past due with no penalty and the Company continues to accrue the interest at 12% per annum.		881,752		881,572
On May 30, 2012, the Company issued a convertible note in the principal amount of $200,000 with interest at 10% per annum due one (1) year from the date of issuance convertible at the lower of (a) the price per share at which shares of capital stock issued in the Financing or (b) the average closing bid price over the thirty (30) day period prior to the Conversion Date. The note with accrued interest of $235,616 was converted to 1,973,337 shares on March 11, 2014.		-		1,739,130
On July 16, 2013, the Company issued a convertible note for $400,000, with consideration of $360,000 and a $40,000 original issue discount. The lender provided $100,000 on July 18, and $ 25,000 on September 26, 2013, respectively, with conversion price at the lesser of $0.26 or 65% of the lowest trade price for the 30 day period before conversion, The notes are due one (1) year from the date of each payment with interest at 12% per annum. These notes were converted as of March 31, 2014.		-		1,762,228
On August 27, 2013, the Company issued a convertible note in the amount of $153,000, convertible at 65% multiplied by the market price, with interest at 8% per annum, due on May 26, 2014. The Note was converted on February and March 2014.		-		2,353,573
On September 26, 2013, the Company issued a convertible note in the principal amount of $27,778 with a 10% Original Issuance Discount ("OID") and a one-time interest charge of 12%. The note is due one (1) year from the date of issuance with the conversion price at 65% of the lowest trade price for the 25 trade day period before the conversion date. The Note was converted to common shares on March 26, 2014.		-		440,571
On October 15, 2013, the Company issued a convertible note in the principal amount of $58,000 with an $8,000 Original Issuance Discount ("OID") and with interest at 10% per annum, convertible at $0.20 per share, due on May 1, 2014. The Note was converted to common shares on March 31, 2014.		-		290,000

On November 21, 2013, the Company issued a convertible note in the principal amount of $53,000, convertible at 65% of the three lowest bids for 30 trading days before the conversion date with interest at 8% per annum, due on August 25, 2014.The principal of the note was converted to 652,709 shares on May 27 and May 28, 2014.	-	812,634
On December 9, 2013, the Company issued a convertible note in the principal amount of $55,556 with a 10% Original Issuance Discount ("OID") and 12% one-time interest. The note is due one (1) year from the date of issuance with the conversion price at 65% of the lowest trade price for the 25 trade day period before the conversion date .	-	881,142
On February 7, 2014, the Company issued a convertible notes in the principal amount of $80,000 convertible at $0.10 per share, with interest at 8% per annum due on February 6, 2015. ???	800,000	-
On February 20, 2014 the Company issued a convertible note in the principal amount of $55,556 with a 10% Original Issuance Discount ("OID") and 12% one-time interest. The note is due February 20, 2015, one (1) year from the date of issuance, convertible at 65% of the lowest trade price for the 25 trade day period before the conversion date. The principal of the note was converted to 1,202,664 shares on August 20, 2014 and September 4, 2014.	-	-
On March 3, 2014 the Company issued a convertible note in the principal amount of $500,000 with a 32% Original Issuance Discount ("OID") that is to be waived upon filing a registration report and convertible at 60% of the two lowest bids for 10 trading days before the conversion date with interest at 8% per annum, due on December 17, 2014. The principal amount of $251,507 was converted to 4,646,371 shares during the quarter ending June 30, 2014 and $88,493 remaining principal was converted to common shares in September, 2014.	-	-
On May 16, 2014 the Company issued a convertible note in the principal amount of $600,000 and convertible at 60% of the two lowest bids for 10 trading days before the conversion date with interest at 8% per annum, due on March 15, 2015. The principal amount of $600,000 was converted to 17,063,771 shares during the quarter ending September 30, 2014.	-	-
On June 23, 2014 the Company issued a convertible note in the principal amount of $150,000 with a 10% Original Issuance Discount ("OID") and 12% one-time interest. The note is due June 22, 2015, one (1) year from the date of issuance, convertible at 65% of the lowest trade price for the 25 trade day period before the conversion date. The principal amount of $28,892 was converted to 700,000 shares on December 29, 2014.	2,934,161	-
On November 21, 2014 the Company issued a convertible note in the principal amount of $110,000 with a 10% Original Issuance Discount ("OID") and 8% one-time interest. The note is due one (1) year from the date of issuance, convertible at 70% of the lowest trade price for the 25 trade day period before the conversion date.	2,665,051	-
On December 17, 2014 the Company issued a convertible note in the principal amount of $222,222 with a 10% Original Issuance Discount ("OID") and 12% one-time interest. The note is due one (1) year from the date of issuance, convertible at 65% of the lowest trade price for the 25 trade day period before the conversion date.	5,383,937	-
On December 30, 2014 the Company issued a convertible note in the principal amount of $1,250,000 with a 20% Original Issuance Discount ("OID"). The note is due on June 30, 2016 convertible at $0.125 per share subject to adjustment stated in the agreement.	10,000,000	-
Sub-total Convertible Note Shares	23,064,901	10,561,070
Warrant Shares
On August 6, 2012, the Company issued (i) warrants to purchase 1,066,667 shares, in the aggregate, of the Company’s common stock to investors (the “investor warrants”) and (ii) warrants to purchase 85,333 shares of the Company's common stock to the placement agent (the "agent warrants") with an exercise price of $0.6405 per share, subject to certain adjustments pursuant to Section 3(b) Subsequent Equity Sales of the SPA, expiring five (5) years from the date of issuance. On February 26, 2013, warrants issued subsequent to these warrants triggered a reset of these warrants exercise price to $0.25 per share and the shares to be issued under the warrants were adjusted to 2,951,424 shares accordingly. On May 8, 2013, the Company completed a private placement at $0.20 per share with gross proceeds more than $100,000; this event triggered the reset of the conversion price of the convertible note to $0.20 per share and the shares to be issued under the warrants were adjusted to 3,689,280 shares accordingly. On May 8, 2013, investors exercised warrants to purchase 2,732,799 shares (853,333 original shares) at $0.20 per share. On February 7, 2014, the number of shares and exercise price of the remaining unexercised warrants were reset to 11,093,791 shares and $0.053365 per share. On June 29, 2014, the number of shares and exercise price of the remaining unexercised warrants were reset to 2,524,320 shares and $0.0426 per share. On July 17, 2014, the number of shares and exercise price of the remaining unexercised warrants were reset to 2,568,753 shares and $0.039 per share	2,568,753	956,481

On February 26, 2013, the Company issued warrants to purchase 1,000,000 and 400,000 shares respectively, or 1,400,000 shares in aggregate, of the Company’s common stock to two (2) note holders in connection with the issuance of convertible notes. The warrants expire five years from the issue date.	1,400,000	1,400,000
On March 15, 2013, the Company issued a warrant to purchase 881,753 shares of the Company’s common stock to the note holder in connection with the issuance of the convertible note. The warrants expire five years from the issue date.	881,753	881,753
On May 6, 2013, the Company issued three (3) series of warrants: Series A warrants include (i) warrants to purchase 1,877,333 shares of the Company’s common stock to the investor and (ii) warrants to purchase 150,187 shares of the Company's common stock to the placement agent (the "agent warrants") with an exercise price of $0.20 per share and full reset feature expiring five (5) years from the date of issuance, which was subsequently reset to 7,035,821 and 562,866 with exercise price being reset to $0.053365 per share. In February 2014, the warrant holders exercised certain warrants and acquired 1,877,333 shares at $0.053365 per share in February 2014. In May 2014, the warrant holders exercised the remaining outstanding warrants and acquired 5,158,487 shares at $0.053365 per share.	-	2,027,520
Series B warrants include (i) warrants to purchase 1,066,666 shares of the Company’s common stock to the investor and (ii) warrants to purchase 85,333 shares of the Company's common stock to the placement agent (the "agent warrants") with an exercise price of $0.25 per share and full reset feature expiring five (5) years from the date of issuance, which was subsequently reset to 4,997,030 and 399,762 with exercise price being reset to $0.053365 per share. In February 2014, the warrant holders exercised certain warrants and acquired 1,066,666 shares at $0.053365 per share. In May 2014, the warrant holders exercised the remaining warrants and acquired 3,930,363 shares at $0.053365 per share in May 2014.	-	1,151,999
Series C warrants include (i) warrants to purchase 2,346,666 shares of the Company’s common stock to the investor and (ii) warrants to purchase 187,733 shares of the Company's  common  stock to the placement agent (the "agent warrants") with an exercise price of $0.25 per share and full reset feature expiring five (5) years from the date of issuance. The warrants are exercisable under the condition of Series A warrants are exercised, which was subsequently reset to 10,997,430 and 879,478 with exercise price being reset to $0.053365 per share. In February 2014, the warrant holders exercised certain warrants and acquired 2,346,666 shares at $0.053365 per share in February 2014. On July 17, 2014, the number of shares and exercise price of the remaining unexercised warrants were reset to $0.039 per share. During the quarter ending December 31, 2014, the warrant holders exercised certain warrants and acquired 8,646,803 shares at $0.039 per share.	3,608,441	2,534,399
On October 15, 2013, the Company issued warrants to purchase 1,000,000 shares of the Company’s common stock to a note holder with an exercise price of $0.25 per share and full reset feature in connection with the issuance of convertible note, which was subsequently reset to 4,684,718 with exercise price being reset to $0.053365 per share in February 2014, all of which were cashless exercised on April 4, 2014.	-	1,000,000
On February 7, 2014, the Company issued warrants to purchase 1,000,000 shares of the Company’s common stock to a note holder with an exercise price of $0.10 per share and full reset feature in connection with the issuance of convertible note, which was subsequently reset to 2,347,418 with exercise price being reset to $0.0426 per share in June 2014. On July 17, 2014, the exercise price of the warrants were reset to $0.039 per share The warrants expire five years from the issue date.	2,564,103	-
On February 15, 2014, the Company issued warrants to purchase 563,874 shares of the Company’s common stock to the placement agent with an exercise price between $0.053365 and $0.30 per share as commission for the issuance of convertible note and conversion. The warrants expire five years from the issue date.	563,874	-

On February 20, 2014, the Company issued warrants to purchase 683,202 shares of the Company’s common stock to a note holder with an exercise price of $0.053365 per share as replacement warrant, all of which were exercised during the quarter ending June 30, 2014.	-	-
On April 8, 2014, the Company issued warrants to purchase 4,000,000 shares of the Company’s common stock to one investor with an exercise price of $0.45 per share in connection with the commons stock purchase. The warrants expire five years from the issue date.	4,000,000	-
On May 15, 2014, the Company issued warrants to purchase 423,931 shares of the Company’s common stock to the placement agent with an exercise price between $0.053365 and $0.30 per share as commission for the conversion of convertible notes. The warrants expire five years from the issue date.	423,931	-
On July 15, 2014, the Company issued warrants to purchase 1,443,624 shares of the Company’s common stock to the placement agent with an exercise price between $0.04875 and $0.0812 per share as commission for the conversion of convertible notes. The warrants expire five years from the issue date.	1,443,624	-
On November 21, 2014, the Company issued warrants to purchase 1,000,000 shares of the Company’s common stock to one investor with an exercise price of $0.10 per share and full reset feature in connection with the issuance of convertible note. The warrants expire five years from the issue date.	1,000,000	-
On December 30, 2014, the Company issued warrants to purchase 10,000,000 shares of the Company’s common stock to one investor with an exercise price of $0.12 per share and full reset feature in connection with the issuance of a convertible note, the warrants are exercisable from June 30, 2015 and expiring seven years from the exercisable date.	10,000,000	-
On December 30, 2014, the Company issued warrants to purchase 600,000 shares of the Company’s common stock to one investor with an exercise price of $0.12 per share and full reset feature as commission with the issuance of a convertible note, the warrants are exercisable from June 30, 2015 and expiring seven years from the exercisable date.	600,000	-
Sub-total Warrant Shares	29,054,479	9,952,152
Total contingent shares issuance arrangement, stock options or warrants	52,119,380	20,513,222